- Home
- SGHT vs LFT Comparison
SGHT vs LFT Comparison
Compare SGHT & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- LFT
- Stock Information
- Founded
- SGHT 2011
- LFT 2012
- Country
- SGHT United States
- LFT United States
- Employees
- SGHT N/A
- LFT N/A
- Industry
- SGHT Medical Specialities
- LFT Real Estate Investment Trusts
- Sector
- SGHT Health Care
- LFT Real Estate
- Exchange
- SGHT Nasdaq
- LFT Nasdaq
- Market Cap
- SGHT 140.1M
- LFT 136.0M
- IPO Year
- SGHT 2021
- LFT N/A
- Fundamental
- Price
- SGHT $3.22
- LFT $2.68
- Analyst Decision
- SGHT Buy
- LFT Buy
- Analyst Count
- SGHT 7
- LFT 3
- Target Price
- SGHT $3.83
- LFT $2.50
- AVG Volume (30 Days)
- SGHT 189.8K
- LFT 149.1K
- Earning Date
- SGHT 05-08-2025
- LFT 05-08-2025
- Dividend Yield
- SGHT N/A
- LFT 15.36%
- EPS Growth
- SGHT N/A
- LFT 18.59
- EPS
- SGHT N/A
- LFT 0.34
- Revenue
- SGHT $79,866,000.00
- LFT $36,218,717.00
- Revenue This Year
- SGHT N/A
- LFT $172.71
- Revenue Next Year
- SGHT $11.17
- LFT $0.46
- P/E Ratio
- SGHT N/A
- LFT $7.85
- Revenue Growth
- SGHT N/A
- LFT 12.91
- 52 Week Low
- SGHT $2.03
- LFT $2.22
- 52 Week High
- SGHT $8.45
- LFT $2.84
- Technical
- Relative Strength Index (RSI)
- SGHT 67.25
- LFT 55.44
- Support Level
- SGHT $2.40
- LFT $2.60
- Resistance Level
- SGHT $3.44
- LFT $2.71
- Average True Range (ATR)
- SGHT 0.28
- LFT 0.13
- MACD
- SGHT 0.11
- LFT 0.02
- Stochastic Oscillator
- SGHT 84.40
- LFT 92.86
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.